Epilepsy Pathway Innovation in Africa
Epilepsy affects over 50 million people across the world. 80% of these people live in low to middle income countries. There is a very high rate of epilepsy in Africa, where misunderstanding and stigma lead to limited diagnoses and treatment.
Epilepsy Pathway Innovation in Africa (EPINA) is a research team based in Oxford that has partnered with leading institutions in Kenya, Ghana and Tanzania. Working in these countries, EPINA aims to:
- better understand the impact of stigma on people with epilepsy
- improve epilepsy knowledge to improve help-seeking and treatment
- develop an app to help healthcare workers to diagnose epilepsy
- develop portable electroencephalograms to diagnose epilepsy in rural settings
- improve medication adherence through text messaging.
EPINA could dramatically change the lives of people with epilepsy in sub Saharan Africa. If successful, we will use our knowledge to ensure that similar work is carried out across other low and middle-income countries.
Visit the EPInA website here: https://epina.web.ox.ac.uk
Subscribe to the EPInA newsletter here: https://epina.web.ox.ac.uk/article/newsletters
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discovery
Journal article
Dellar ER. et al, (2026), Clinical Proteomics, 23
Molecular correlates of sleep deprivation in the mouse brain identified by meta-analysis of microarray data.
Journal article
Abdalla OHMH. et al, (2026), Neurobiol Sleep Circadian Rhythms, 21
Inter‐Shot Motion Correction of Segmented 3D ‐ GRASE ASL Perfusion Imaging With Self‐Navigation and CAIPI
Journal article
Hu M. et al, (2026), Magnetic Resonance in Medicine, 96, 1557 - 1571
Sex-specific molecular signatures in persistent pain after whiplash injury: an exploratory analysis
Journal article
Fundaun J. et al, (2026), PAIN Reports, 11